Medicare Enrolled
Dr. William Wilson, MD
Rheumatology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wilson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wilson
Dr. William Wilson is a rheumatology specialist in Atlanta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wilson performed 39,721 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wilson received a total of $353,926 from 72 pharmaceutical and/or device companies across 2198 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wilson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in GA
$353,926 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗39,721
Medicare services
Top 17% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
17,200 | $10 | $84 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
15,025 | $33 | $130 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $43 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
580 | $1 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
377 | $80 | $221 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
363 | $49 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
324 | $57 | $147 |
| Injection, methylprednisolone acetate, 40 mg | 284 | $6 | $37 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
254 | $8 | $54 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
230 | $10 | $78 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
197 | $98 | $600 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
170 | $12 | $68 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
136 | $51 | $249 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
119 | $21 | $130 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
108 | $1 | $2 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
99 | $21 | $133 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $6 | $300 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
68 | $4 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $101 | $325 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
46 | $30 | $160 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
42 | $39 | $199 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
41 | $0 | $70 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
16 | $23 | $141 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
82.5% high complexity
15.6% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$353,926
Total received (2018-2024)
Avg $50,561/year across 7 years
Top 2% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
2,198
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$45,455
2023
$47,620
2022
$51,310
2021
$37,466
2020
$40,871
2019
$64,116
2018
$67,088
Payments by company (2024)
Janssen Biotech, Inc.
$17,698
Mallinckrodt Hospital Products Inc.
$8,223
ABBVIE INC.
$8,104
Amgen Inc.
$7,462
Novartis Pharmaceuticals Corporation
$586
UCB, Inc.
$514
PFIZER INC.
$389
ANI Pharmaceuticals, Inc.
$372
AstraZeneca Pharmaceuticals LP
$340
GENZYME CORPORATION
$328
GlaxoSmithKline, LLC.
$283
E.R. Squibb & Sons, L.L.C.
$202
Aurinia Pharma U.S., Inc.
$191
Alexion Pharmaceuticals, Inc.
$190
Azurity Pharmaceuticals, Inc.
$98
Radius Health, Inc.
$75
Sandoz Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
TerSera Therapeutics LLC
$51
Takeda Pharmaceuticals U.S.A., Inc.
$49
Organon Llc
$46
SOBI, INC
$46
Actelion Pharmaceuticals US, Inc.
$39
SCILEX PHARMACEUTICALS INC.
$38
Octapharma USA, Inc.
$14
Top 3 companies account for 74.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$62,919
Horizon Therapeutics plc
$40,168
GlaxoSmithKline, LLC.
$38,801
AbbVie Inc.
$30,174
AbbVie, Inc.
$29,484
Janssen Biotech, Inc.
$26,030
ABBVIE INC.
$25,764
Mallinckrodt Hospital Products Inc.
$20,779
Mallinckrodt LLC
$17,128
Mallinckrodt Enterprises LLC
$16,029
AstraZeneca Pharmaceuticals LP
$12,681
PFIZER INC.
$10,451
UCB, Inc.
$6,938
Novartis Pharmaceuticals Corporation
$4,203
Lilly USA, LLC
$1,206
E.R. Squibb & Sons, L.L.C.
$1,191
GENZYME CORPORATION
$1,180
Aurinia Pharma U.S., Inc.
$1,010
SANOFI-AVENTIS U.S. LLC
$867
ANI Pharmaceuticals, Inc.
$804
Celgene Corporation
$623
Genentech USA, Inc.
$604
Radius Health, Inc.
$561
Alexion Pharmaceuticals, Inc.
$332
Boehringer Ingelheim Pharmaceuticals, Inc.
$281
United Therapeutics Corporation
$265
Janssen Scientific Affairs, LLC
$260
Galt Pharmaceuticals, LLC
$244
Sobi, Inc
$207
MEDEXUS PHARMA, INC.
$178
Horizon Pharma plc
$168
Azurity Pharmaceuticals, Inc.
$167
Antares Pharma, Inc.
$157
Ironwood Pharmaceuticals, Inc
$137
IDORSIA PHARMACEUTICALS US INC
$125
FIDIA PHARMA USA INC.
$120
MEDAC PHARMA, INC.
$112
intraFUSION GP, LLC
$111
BioDelivery Sciences International, Inc.
$100
Gilead Sciences, Inc.
$98
Sandoz Inc.
$92
Hikma Pharmaceuticals USA
$86
Organon LLC
$82
Exeltis, USA Inc.
$81
IBSA Pharma Inc.
$74
Zyla Life Sciences
$67
SOBI, INC
$60
TerSera Therapeutics LLC
$51
Takeda Pharmaceuticals U.S.A., Inc.
$49
Organon Llc
$46
Eisai Inc.
$45
Bioventus LLC
$43
Actelion Pharmaceuticals US, Inc.
$39
SCILEX PHARMACEUTICALS INC.
$38
Mylan Institutional Inc.
$37
ASSERTIO THERAPEUTICS, Inc.
$35
Octapharma USA, Inc.
$30
DePuy Synthes Sales Inc.
$30
Merck Sharp & Dohme Corporation
$27
TG THERAPEUTICS, INC.
$27
Egalet US Inc
$25
RECORDATI_RARE_DISEASES_INC.
$25
Alkermes, Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$23
Assertio Therapeutics, Inc.
$20
Flexion Therapeutics, Inc.
$20
Merck Sharp & Dohme LLC
$20
Teva Pharmaceuticals USA, Inc.
$15
West-Ward Pharmaceuticals
$14
Daiichi Sankyo Inc.
$14
Zyla Life Sciences, Inc.
$13
RedHill Biopharma Inc.
$12
Top 3 companies account for 40.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · ARISTADA · AVSOLA · Actemra · Aimovig · BELBUCA · BELSOMRA · BENLYSTA · BRIUMVI · Bimzelx · COSENTYX · CYLTEZO · Cambia · Cimzia · DUEXIS · DUZALLO · Dayvigo · Durolane · EMGALITY · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN-3 · HORIZANT · HUMIRA · HYALGAN · HYQVIA · HYRIMOZ · Horizant · Hulio · Humira · Hymovis · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LINZESS · LUPKYNIS · LYRICA · Licart · MOVANTIK · Mitigare · Movantik · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Orphengesic Forte · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOVUNA · SPRIX · STELARA · STRENSIQ · SYLVANT · Strensiq · TALTZ · TAVNEOS · TREMFYA · TYVASO · Tavneos · Tirosint · Truxima · Tymlos · ULTOMIRIS · XELJANZ · XYOSTED · ZORVOLEX · ZTLido · Zilretta · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
90
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
PIEDMONT HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wilson is a mixed practice specialist, with above-average Medicare volume (top 17% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wilson experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Wilson performed 17,200 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wilson receive payments from pharmaceutical companies?
Yes. Dr. Wilson received a total of $353,926 from 72 companies across 2,198 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilson's costs compare to other rheumatologists in Atlanta?
Dr. Wilson's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Atlanta
Browse rheumatologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology